Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Feb;79(2):637–642. doi: 10.1172/JCI112860

Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma.

E H Lipford, H R Smith, S Pittaluga, E S Jaffe, A D Steinberg, J Cossman
PMCID: PMC424152  PMID: 3805286

Abstract

To investigate the relationship of the lymphoid hyperplasia of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) to supervening malignant lymphoma, we subjected DNA from lymph nodes and peripheral blood mononuclear cells from five AILD patients to Southern blot analysis to detect clonal rearrangements of immunoglobulin and T-cell receptor genes. Lymph nodes and peripheral blood from AILD patients were found to contain clones of lymphoid cells harboring either immunoglobulin or T-cell receptor gene rearrangements that, in some instances, regressed during the course of disease. A lymph node from one patient was involved by immunoblastic lymphoma and manifested an additional gene rearrangement pattern not seen in premalignant specimens from that patient. In contrast, DNA obtained from normal peripheral blood mononuclear cells and 11 examples of other forms of lymphoid hyperplasia showed no gene rearrangements. As a disorder of cellular immunoregulation in which lymphoid cells may escape normal growth controls, AILD provides a natural model to dissect stages of lymphomagenesis in man.

Full text

PDF
637

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisenberg A. C., Krontiris T. G., Mak T. W., Wilkes B. M. Rearrangement of the gene for the beta chain of the T-cell receptor in T-cell chronic lymphocytic leukemia and related disorders. N Engl J Med. 1985 Aug 29;313(9):529–533. doi: 10.1056/NEJM198508293130901. [DOI] [PubMed] [Google Scholar]
  2. Arnold A., Cossman J., Bakhshi A., Jaffe E. S., Waldmann T. A., Korsmeyer S. J. Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med. 1983 Dec 29;309(26):1593–1599. doi: 10.1056/NEJM198312293092601. [DOI] [PubMed] [Google Scholar]
  3. Bertness V., Kirsch I., Hollis G., Johnson B., Bunn P. A., Jr T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N Engl J Med. 1985 Aug 29;313(9):534–538. doi: 10.1056/NEJM198508293130902. [DOI] [PubMed] [Google Scholar]
  4. Boros L., Bhaskar A. G., D'Souza J. P. Monoclonal evolution of angioimmunoblastic lymphadenopathy. Am J Clin Pathol. 1981 Jun;75(6):856–860. doi: 10.1093/ajcp/75.6.856. [DOI] [PubMed] [Google Scholar]
  5. Cleary M. L., Chao J., Warnke R., Sklar J. Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc Natl Acad Sci U S A. 1984 Jan;81(2):593–597. doi: 10.1073/pnas.81.2.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cleary M. L., Sklar J. Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet. 1984 Sep 1;2(8401):489–493. doi: 10.1016/s0140-6736(84)92566-2. [DOI] [PubMed] [Google Scholar]
  7. Croce C. M., Tsujimoto Y., Erikson J., Nowell P. Chromosome translocations and B cell neoplasia. Lab Invest. 1984 Sep;51(3):258–267. [PubMed] [Google Scholar]
  8. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  9. Flandrin G. Angioimmunoblastic lymphadenopathy: clinical, biologic, and follow-up study of 14 cases. Recent Results Cancer Res. 1978;64:247–262. doi: 10.1007/978-3-642-81246-0_29. [DOI] [PubMed] [Google Scholar]
  10. Flug F., Pelicci P. G., Bonetti F., Knowles D. M., 2nd, Dalla-Favera R. T-cell receptor gene rearrangements as markers of lineage and clonality in T-cell neoplasms. Proc Natl Acad Sci U S A. 1985 May;82(10):3460–3464. doi: 10.1073/pnas.82.10.3460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Frizzera G., Moran E. M., Rappaport H. Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet. 1974 Jun 1;1(7866):1070–1073. doi: 10.1016/s0140-6736(74)90553-4. [DOI] [PubMed] [Google Scholar]
  12. Frizzera G., Moran E. M., Rappaport H. Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course. Am J Med. 1975 Dec;59(6):803–818. doi: 10.1016/0002-9343(75)90466-0. [DOI] [PubMed] [Google Scholar]
  13. Greer J. P., York J. C., Cousar J. B., Mitchell R. T., Flexner J. M., Collins R. D., Stein R. S. Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases. J Clin Oncol. 1984 Jul;2(7):788–798. doi: 10.1200/JCO.1984.2.7.788. [DOI] [PubMed] [Google Scholar]
  14. Honda M., Smith H. R., Steinberg A. D. Studies of the pathogenesis of angioimmunoblastic lymphadenopathy. J Clin Invest. 1985 Jul;76(1):332–340. doi: 10.1172/JCI111966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kaneko Y., Larson R. A., Variakojis D., Haren J. M., Rowley J. D. Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy. Blood. 1982 Oct;60(4):877–887. [PubMed] [Google Scholar]
  16. Klajman A., Yaretzky A., Schneider M., Holoshitz Y., Shneur A., Griffel B. Angioimmunoblastic lymphadenopathy with paraproteinemia: a T- and B-cell disorder. Cancer. 1981 Dec 1;48(11):2433–2437. doi: 10.1002/1097-0142(19811201)48:11<2433::aid-cncr2820481116>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  17. Klein G. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc Natl Acad Sci U S A. 1979 May;76(5):2442–2446. doi: 10.1073/pnas.76.5.2442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Korsmeyer S. J., Arnold A., Bakhshi A., Ravetch J. V., Siebenlist U., Hieter P. A., Sharrow S. O., LeBien T. W., Kersey J. H., Poplack D. G. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest. 1983 Feb;71(2):301–313. doi: 10.1172/JCI110770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Korsmeyer S. J., Greene W. C., Cossman J., Hsu S. M., Jensen J. P., Neckers L. M., Marshall S. L., Bakhshi A., Depper J. M., Leonard W. J. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4522–4526. doi: 10.1073/pnas.80.14.4522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lapes M. J., Vivacqua R. J., Antoniades K. Letter: Immunoblactic lymphadenopathy associated with phenytoin (diphenylhydantoin). Lancet. 1976 Jan 24;1(7952):198–198. doi: 10.1016/s0140-6736(76)91307-6. [DOI] [PubMed] [Google Scholar]
  21. Lukes R. J., Tindle B. H. Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease. N Engl J Med. 1975 Jan 2;292(1):1–8. doi: 10.1056/NEJM197501022920101. [DOI] [PubMed] [Google Scholar]
  22. Mazur E. M., Lovett D. H., Enriquez R. E., Breg W. R., Jr, Papac R. J. Angioimmunoblastic lymphadenopathy evolution to a Burkitt-like lymphoma. Am J Med. 1979 Aug;67(2):317–324. doi: 10.1016/0002-9343(79)90407-8. [DOI] [PubMed] [Google Scholar]
  23. Mountz J. D., Steinberg A. D., Klinman D. M., Smith H. R., Mushinski J. F. Autoimmunity and increased c-myb transcription. Science. 1984 Nov 30;226(4678):1087–1089. doi: 10.1126/science.6494925. [DOI] [PubMed] [Google Scholar]
  24. Nathwani B. N., Rappaport H., Moran E. M., Pangalis G. A., Kim H. Evolution of immunoblastic lymphoma in angioimmunoblastic lymphadenopathy. Recent Results Cancer Res. 1978;64:235–240. doi: 10.1007/978-3-642-81246-0_27. [DOI] [PubMed] [Google Scholar]
  25. Nathwani B. N., Rappaport H., Moran E. M., Pangalis G. A., Kim H. Malignant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer. 1978 Feb;41(2):578–606. doi: 10.1002/1097-0142(197802)41:2<578::aid-cncr2820410226>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  26. Pangalis G. A., Moran E. M., Nathwani B. N., Zelman R. J., Kim H., Rappaport H. Angioimmunoblastic lymphadenopathy. Long-term follow-up study. Cancer. 1983 Jul 15;52(2):318–321. doi: 10.1002/1097-0142(19830715)52:2<318::aid-cncr2820520221>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  27. Pelicci P. G., Knowles D. M., 2nd, Dalla Favera R. Lymphoid tumors displaying rearrangements of both immunoglobulin and T cell receptor genes. J Exp Med. 1985 Sep 1;162(3):1015–1024. doi: 10.1084/jem.162.3.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rowley J. D. Biological implications of consistent chromosome rearrangements in leukemia and lymphoma. Cancer Res. 1984 Aug;44(8):3159–3168. [PubMed] [Google Scholar]
  29. Rudders R. A., DeLellis R. Immunoblastic lymphadenopathy. A mixed proliferation of T and B lymphocytes. Am J Clin Pathol. 1977 Oct;68(4):518–521. doi: 10.1093/ajcp/68.4.518. [DOI] [PubMed] [Google Scholar]
  30. Shearer W. T., Ritz J., Finegold M. J., Guerra I. C., Rosenblatt H. M., Lewis D. E., Pollack M. S., Taber L. H., Sumaya C. V., Grumet F. C. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. N Engl J Med. 1985 May 2;312(18):1151–1159. doi: 10.1056/NEJM198505023121804. [DOI] [PubMed] [Google Scholar]
  31. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  32. Starzl T. E., Nalesnik M. A., Porter K. A., Ho M., Iwatsuki S., Griffith B. P., Rosenthal J. T., Hakala T. R., Shaw B. W., Jr, Hardesty R. L. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet. 1984 Mar 17;1(8377):583–587. doi: 10.1016/s0140-6736(84)90994-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Toyonaga B., Yanagi Y., Suciu-Foca N., Minden M., Mak T. W. Rearrangements of T-cell receptor gene YT35 in human DNA from thymic leukaemia T-cell lines and functional T-cell clones. 1984 Sep 27-Oct 3Nature. 311(5984):385–387. doi: 10.1038/311385a0. [DOI] [PubMed] [Google Scholar]
  34. Waldmann T. A., Davis M. M., Bongiovanni K. F., Korsmeyer S. J. Rearrangements of genes for the antigen receptor on T cells as markers of lineage and clonality in human lymphoid neoplasms. N Engl J Med. 1985 Sep 26;313(13):776–783. doi: 10.1056/NEJM198509263131303. [DOI] [PubMed] [Google Scholar]
  35. Weisenburger D. D. Immunoblastic lymphadenopathy associated with methyldopa therapy: a case report. Cancer. 1978 Nov;42(5):2322–2327. doi: 10.1002/1097-0142(197811)42:5<2322::aid-cncr2820420532>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  36. Weiss L. M., Hu E., Wood G. S., Moulds C., Cleary M. L., Warnke R., Sklar J. Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Engl J Med. 1985 Aug 29;313(9):539–544. doi: 10.1056/NEJM198508293130903. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES